A Mixed-Method Approach to Evaluate a Pharmacist Intervention for Veterans With Hypertension

Journal of Clinical Hypertension

Volumn 16, Issue 2, 2014, Pages 133-140

  Parker, Christopher P ^a   Cunningham, Cassie L ^b   Carter, Barry L ^a,b,c   Vander Weg, Mark W ^b,c,d   Richardson, Kelly K ^b   Rosenthal, Gary E ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d E11 SSH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMANS; HYPERTENSION; IOWA; MALE; PATIENT SATISFACTION; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; VETERANS;

EID: 84893871486     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12250     Document Type: Article

References (28)

1. Stamler J, Rose G, Stamler R, et al. INTERSALT study findings. Public health and medical care implications. Hypertension. 1989;14:570-577.
2. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
3. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
4. Fletcher RD, Amdur RL, Kolodner R, et al. Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository. Circulation. 2012;125:2462-2468.
5. VA/DoD Clinical practice guideline for diagnosis and management of hypertension in the primary care setting. Department of Veterans Administration, Department of Defense. 2004, Revision 2005.
6. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. Arch Intern Med. 1984;144:1159-1162.
7. Carter BL, Zillich AJ, Elliott WJ. How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens (Greenwich). 2003;5:31-37.
8. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy. 1997;17:140-147.
9. Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy. Arch Intern Med. 1981;141:1441-1444.
10. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274-1285.
11. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash). 1996;36:443-451.
12. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000;20:1384-1389.
13. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142-161.
14. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288:2421-2431.
15. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
16. Kaboli P, Hoth A, Carter BL, et al. The VA Enhanced Pharmacy Outpatient Clinic (EPOC) Study: a randomized-controlled pharmacist-physician intervention trial. J Gen Intern Med. 2004;1:227.
17. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
18. Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005;8:1198-1203.
19. Bandura A, Jeffery RW, Wright CL. Efficacy of participant modeling as a function of response induction aids. J Abnorm Psychol. 1974;83:56-64.
20. Bandura A, Reese L, Adams NE. Microanalysis of action and fear arousal as a function of differential levels of perceived self-efficacy. J Pers Soc Psychol. 1982;43:5-21.
21. Bandura A. Self-regulatory mechanisms governing the impact of social comparison on complex decision making. J Person Social Pyschol. 1991;60:941-951.
22. Bandura A. Self Efficacy in Changing Societies. Cambridge, UK: Cambridge University Press; 1995.
23. ® 9.3. USA: SAS Institute Inc; 2012.
24. Carter BL, Bergus GR, Dawson JD, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008;10:260-271.
25. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996-2002.
26. Bex SD, Boldt AS, Needham SB, et al. Effectiveness of a hypertension care management program provided by clinical pharmacists for veterans. Pharmacotherapy. 2011;31:31-38.
27. Nelson MR, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust. 2006;185:487-489.
28. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22:231-255.